By Professor Adam Jaffe

Preprints

Dayaratne WL; Torres-Cadena R; Schmitt BP; Westrick EM; Jaffe A, 2023, Hybrid bronzes: mixed-valence organic-inorganic metal oxides as a tunable material platform, http://dx.doi.org/10.26434/chemrxiv-2023-v6h2h

Hartley NA; Pugh SM; Xu Z; Leong DCY; Jaffe A; Forse AC, 2023, Quinone-functionalised carbons as new materials for electrochemical carbon dioxide capture, http://dx.doi.org/10.26434/chemrxiv-2023-ls7mc-v2

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v1

McKnight L; Schultz A; Vidic N; Palmer E; Jaffe A, 2022, Learning to make a difference for chILD: Value creation through network collaboration and team science, http://dx.doi.org/10.22541/au.166740302.29601419/v1

Stiboy E; Chan M; Islam MS; L GS; Lui K; Jaffe A; Homaira N, 2022, Variation in clinical practice guidelines for use of palivizumab in preventing severe respiratory syncytial viral (RSV) disease in high-risk infants, http://dx.doi.org/10.22541/au.166419726.62754781/v2

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Capraro A; Fawcett L; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, In silicoand functional characterisation of an ultra-rareCFTRmutation identifies novel lasso motif interactions regulating channel gating, http://dx.doi.org/10.1101/2021.12.12.472297

Wong S; Awatade N; Astore M; Allan K; Carnell M; Slapetova I; Chen P-C; Setiadi J; Pandzic E; Fawcett L; Widger J; Whan R; Griffith R; Ooi C; Kuyucak S; Jaffe A; Waters S, 2021, Molecular dynamics and theratyping in airway and gut organoids reveal R352Q-CFTR conductance defect, http://dx.doi.org/10.1101/2021.08.11.456003

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v3

Hewson C; Capraro A; Wong S; Pandzic E; Fernando BSM; Awatade N; Zhong L; Hart-Smith G; Whan R; Thomas S; Jaffe A; Bridge W; Waters S, 2020, Novel antioxidant therapy with the immediate precursor to glutathione, γ-glutamylcysteine (GGC), ameliorates LPS-induced cellular stress in anin vitrocystic fibrosis model, http://dx.doi.org/10.1101/2020.05.27.119990

Jaffe A; Ziebel M; Halat D; Biggins N; Murphy R; Chakarawet K; Reimer J; Long J, 2020, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v4

Awatade N; Wong S; Pandzic E; Slapetova I; Capraro A; Zhong L; Turgutoglu N; Fawcett L; Whan R; Jaffe A; Waters S, 2020, Significant functional differences despite morphological and molecular similarity in fully differentiated matched Conditionally Reprogrammed (CRC) and Feeder free dual SMAD inhibited expanded human nasal epithelial cells, http://dx.doi.org/10.1101/2020.05.29.120006

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v2

Jaffe A; Ziebel M; Halat DM; Biggins N; Murphy R; Chakarawet K; Reimer JA; Long JR, 2019, Selective, High-Temperature O2 Adsorption in Chemically Reduced, Redox-Active Iron-Pyrazolate Metal–Organic Frameworks, http://dx.doi.org/10.26434/chemrxiv.9922541.v1

Stick SM; Foti A; Ware RS; Tiddens HAWM; Clements BS; Armstrong DS; Selvadurai H; Tai A; Cooper PJ; Byrnes CA; Belessis Y; Wainwright C; Jaffe A; Robinson P; Saiman L; Sly PD, The Effect of Azithromycin on Structural Lung Disease in Infants with Cystic Fibrosis (COMBAT CF): A Phase 3, Randomised, Double-Blind, Placebo-Controlled Clinical Trial, http://dx.doi.org/10.2139/ssrn.3990938

Other

Strachan RE; Jaffé A, 2011, Recommendations for managing paediatric empyema thoracis

Back to profile page